SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-16-000085
Filing Date
2016-05-05
Accepted
2016-05-05 16:57:02
Documents
45
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ebio-033116x10q.htm 10-Q 772924
2 EXHIBIT 31.1 ebio-033116x311.htm EX-31.1 12074
3 EXHIBIT 31.2 ebio-033116x312.htm EX-31.2 11931
4 EXHIBIT 32.1 ebio-033116x321.htm EX-32.1 6980
  Complete submission text file 0001485003-16-000085.txt   2934630

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ebio-20160331.xml EX-101.INS 464949
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebio-20160331.xsd EX-101.SCH 24133
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebio-20160331_cal.xml EX-101.CAL 40406
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebio-20160331_def.xml EX-101.DEF 77153
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebio-20160331_lab.xml EX-101.LAB 314123
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebio-20160331_pre.xml EX-101.PRE 178113
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 161624721
SIC: 2834 Pharmaceutical Preparations